StonvexLoading…
StonvexStonvexStonvexCore line items from NL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $40.57M | $158.28M | $120.59M | $80.64M |
Operating Income | $4.11M | $10.68M | $7.80M | $5.95M |
Net Income | $4.34M | $-37.83M | $-6.85M | $1.02M |
EPS (Diluted) | $0.09 | $-0.77 | $-0.14 | $0.02 |
Total Assets | $461.19M | $464.22M | $500.20M | $523.70M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $101.91M | $110.61M | $101.92M | $111.47M |
Free Cash Flow OCF − CapEx | $-3.95M | $-40.15M | $-35.40M | $-42.35M |
Shares Outstanding | 48.86M | 48.86M | 48.85M | 48.85M |